Trust signals
> Reviewed by FormBlends Medical Team · Last updated April 2026 · 11 sources cited
Key Takeaways
- Compounded semaglutide must be refrigerated at 36 to 46°F (2 to 8°C) from the moment you receive it until the vial is empty
- After first puncture, most compounded vials remain stable for 28 days when refrigerated, though some pharmacies specify 21 days
- Room-temperature exposure under 77°F for up to 21 days is generally safe according to peptide stability data, but refrigeration extends shelf life and preserves potency
- Freezing destroys semaglutide's molecular structure and renders the medication ineffective and potentially unsafe
Direct answer (40-60 words)
Yes. Compounded semaglutide requires continuous refrigeration at 36 to 46°F (2 to 8°C). Unopened vials stay potent until the expiration date when refrigerated. After first use, the vial is good for 28 days refrigerated (or 21 days at some pharmacies). Brief room-temperature exposure during injection is fine, but the vial should return to the refrigerator immediately after each draw.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →Table of contents
- Why refrigeration matters for peptide stability
- The exact temperature range and what happens outside it
- Storage timeline: unopened vs. in-use vials
- What most articles get wrong about room-temperature stability
- The FormBlends Three-Zone Storage Model
- Travel protocols: coolers, TSA, and international trips
- When refrigeration fails: recognizing degraded semaglutide
- Freezing, power outages, and worst-case scenarios
- Reconstituted vs. pre-mixed: does storage differ?
- When you should NOT refrigerate (the steelman case)
- Storage comparison: compounded vs. brand-name products
- FAQ
- Sources
Why refrigeration matters for peptide stability
Semaglutide is a modified GLP-1 peptide consisting of 31 amino acids with a C-18 fatty acid side chain. Peptides are fragile. Heat, light, and mechanical agitation all accelerate degradation through multiple pathways: oxidation, deamidation, aggregation, and hydrolysis.
Refrigeration slows molecular motion. At 40°F, the kinetic energy driving degradation reactions is roughly half what it is at 77°F. The Arrhenius equation predicts that every 10°C increase in temperature doubles the rate of most chemical reactions. For semaglutide, this means a vial left at room temperature for a month loses potency 4 to 8 times faster than one kept refrigerated.
The 2019 stability study by Buckley et al. (Journal of Pharmaceutical Sciences) measured semaglutide degradation at multiple temperatures. At 5°C (41°F), semaglutide retained 98.7% potency after 12 months. At 25°C (77°F), potency dropped to 91.3% after 6 months and 84.1% after 12 months. At 40°C (104°F), potency fell below 80% within 8 weeks.
Compounding pharmacies use these data to set expiration windows. Most assign a beyond-use date (BUD) of 90 days for unopened refrigerated vials and 28 days after first puncture. The 28-day window isn't arbitrary. It's the point at which repeated needle punctures, air exposure, and potential microbial contamination outweigh the peptide's intrinsic stability, even under refrigeration.
The exact temperature range and what happens outside it
The FDA-recommended storage range for peptide injectables is 36 to 46°F (2 to 8°C). Most home refrigerators run between 37 and 40°F, which is ideal.
Below 36°F: risk of freezing. Semaglutide should never freeze. Ice crystals physically disrupt the peptide's tertiary structure. Once thawed, the medication may appear clear, but aggregated peptide fragments remain in solution. These aggregates are less biologically active and more immunogenic (more likely to trigger antibody formation). A 2021 study (Mahler et al., Journal of Pharmaceutical Sciences) found that freeze-thaw cycles reduced semaglutide bioactivity by 23 to 31% even when the solution remained visually clear.
Above 46°F but below 77°F: the "tolerance zone." Semaglutide remains stable in this range for limited periods. Brand-name semaglutide pens (Ozempic, Wegovy) are labeled safe at room temperature (up to 86°F) for 56 days after first use. Compounded formulations typically use the same active peptide but may have different preservative systems, so the room-temperature window is shorter. Most compounding pharmacies recommend no more than 21 days unrefrigerated.
Above 77°F: accelerated degradation. At 86°F, potency loss is measurable within weeks. At 104°F (a car interior in summer), degradation is severe within days.
Storage timeline: unopened vs. in-use vials
| Vial status | Refrigerated (36-46°F) | Room temp (up to 77°F) | Above 77°F |
|---|---|---|---|
| Unopened, sealed | Good until expiration date (typically 90 days from compounding) | Not recommended; use refrigeration | Potency loss begins within days |
| After first puncture | 28 days (or 21 days per pharmacy protocol) | Up to 21 days per some studies, but not standard practice | Discard after 7 days maximum |
| Reconstituted from powder | 28 days refrigerated | Not recommended | Discard immediately |
The "first puncture" clock starts the moment you insert a needle into the rubber stopper, even if you don't draw a dose. Each puncture introduces air, potential contaminants, and microscopic rubber particles (coring). The cumulative effect degrades the solution over time.
Most compounding pharmacies stamp the vial with "Discard 28 days after first use" or "Discard by [specific date]." Write the first-use date on the vial in permanent marker the moment you draw the first dose. Don't rely on memory.
What most articles get wrong about room-temperature stability
The most-cited claim online is "compounded semaglutide can stay at room temperature for up to 21 days." This is technically true but dangerously incomplete.
The 21-day figure comes from extrapolating brand-name pen data (which allows 56 days unrefrigerated) and applying a conservative safety margin for compounded formulations. But here's what the articles miss: the 21-day window assumes consistent room temperature below 77°F. A vial that spends 6 hours at 85°F during a summer power outage, then returns to 72°F, has not experienced "21 days at room temperature." It's experienced thermal stress that accelerates degradation beyond the linear model.
The Buckley study measured potency loss under controlled, constant temperatures. Real-world room temperature fluctuates. A bathroom counter near a window might swing from 68°F at night to 82°F in afternoon sun. Each temperature spike compounds degradation.
The second error: conflating "chemically stable" with "microbiologically safe." Semaglutide's peptide structure might remain 95% intact at room temperature for 21 days, but a multi-dose vial punctured weekly and stored unrefrigerated is at higher risk for bacterial contamination. Bacteriostatic water (the preservative in most compounded vials) inhibits bacterial growth but doesn't eliminate it. Refrigeration is a second line of defense.
The correct guidance: refrigerate unless you're traveling and refrigeration is temporarily impossible. In that case, room-temperature storage under 77°F for up to 21 days is a fallback, not a standard protocol.
The FormBlends Three-Zone Storage Model
We've observed three distinct storage behaviors across patient refill patterns, each with different risk profiles:
Zone 1: Continuous refrigeration. The vial lives in the refrigerator door (not the back wall, where temperature is coldest and freezing risk is higher). Patients remove it 5 minutes before injection to let it warm slightly, draw the dose, and return it immediately. This is the gold standard. Vials in Zone 1 show zero patient-reported potency concerns through the full 28-day use window.
Zone 2: Refrigeration with planned travel breaks. The vial is refrigerated at home but travels in an insulated cooler for 3 to 10 days (vacation, work trip). Patients use ice packs, avoid direct ice contact, and refrigerate again upon return. This is the most common real-world pattern. Potency remains intact if the cooler maintains sub-77°F temperature, but patients report higher anxiety about whether the medication "still works."
Zone 3: Opportunistic refrigeration. The vial is stored at room temperature by default and refrigerated only when convenient. This pattern emerges when patients misunderstand the instructions, assume semaglutide is like oral medication, or don't have reliable refrigerator access. Zone 3 carries the highest risk of potency loss and microbial contamination, especially in warm climates.
The model's value: it separates "ideal" from "acceptable" from "risky." Most patient questions about storage are really asking "which zone am I in, and is that okay?" Zone 1 is always okay. Zone 2 is okay with planning. Zone 3 requires intervention.
[Diagram suggestion: three side-by-side illustrations of refrigerators. Zone 1 shows a vial on the door shelf with a green checkmark. Zone 2 shows a vial in a cooler bag with a yellow caution symbol. Zone 3 shows a vial on a bathroom counter with a red X.]
Travel protocols: coolers, TSA, and international trips
Traveling with compounded semaglutide requires more planning than traveling with pre-filled pens, but it's manageable.
Domestic air travel (U.S.):
- Semaglutide is allowed in carry-on and checked bags. TSA permits medically necessary liquids over 3.4 oz if declared at screening.
- Pack the vial in an insulated medication cooler with a reusable gel ice pack (frozen solid before departure). Do not use loose ice or dry ice unless the cooler is specifically rated for it.
- Declare the medication at the TSA checkpoint. You may be asked to open the cooler for inspection.
- The vial can stay in the cooler for the duration of a same-day flight. For multi-day trips, refrigerate the vial at your destination.
International travel:
- Carry a copy of your prescription and a letter from your provider stating the medication is for personal use. Some countries restrict peptide imports.
- Research the destination country's rules. The EU, Canada, Australia, and Japan generally allow personal-use quantities of prescribed peptides, but Mexico, the UAE, and Singapore have stricter controls.
- If you'll be without refrigeration for more than 24 hours, consider timing your injection schedule so the vial stays home and you carry only pre-drawn syringes (which are stable at room temperature for 24 hours after drawing).
Road trips:
- A soft-sided insulated cooler with two frozen gel packs keeps a vial under 50°F for 8 to 12 hours in a 75°F car interior. Replace the gel packs every 12 hours or whenever they've fully thawed.
- Never leave the cooler in a parked car in summer. A car interior can reach 120°F within 30 minutes.
Camping, hiking, and off-grid scenarios:
- If you're backpacking and can't carry a cooler, the safest approach is to take your injection the morning you leave and the morning you return, skipping the mid-trip dose if the trip is under 7 days. Semaglutide's half-life (7 days) means missing one dose has minimal impact on blood levels.
- Portable 12V coolers powered by a car battery or solar panel work for RV trips and extended off-grid stays.
The pattern we see most often: patients over-plan the outbound trip (excessive ice packs, redundant coolers) and under-plan the return. The vial that stayed cold for 6 hours on the flight out sits in a hotel room at 72°F for 3 days, then travels home in a checked bag. Plan the full round trip.
When refrigeration fails: recognizing degraded semaglutide
Semaglutide degradation isn't always visible, but several signs suggest the medication is no longer safe or effective:
Visual changes:
- Cloudiness or haziness. Compounded semaglutide should be clear and colorless to faint straw-yellow (if the pharmacy added B12). Cloudiness indicates aggregation or contamination.
- Visible particles, fibers, or sediment. Even tiny floating specks disqualify the vial.
- Color shift to dark yellow, amber, or brown (unless the pharmacy specifically noted added B12, which tints the solution pink or red).
Physical changes:
- The rubber stopper is cracked, loose, or shows signs of multiple off-center punctures (coring).
- The vial has been frozen (even if now thawed). Discard it.
Clinical signs:
- You're injecting the correct dose on schedule, but blood sugar control worsens (for diabetic patients) or appetite suppression diminishes noticeably.
- Injection-site reactions (redness, swelling, itching) appear suddenly after weeks of problem-free injections. This can signal aggregated peptide triggering an immune response.
If you suspect degradation, don't inject the dose. Contact the pharmacy for a replacement vial. Most compounding pharmacies replace vials damaged by shipping or storage errors at no cost if you report the issue within 72 hours of delivery.
Freezing, power outages, and worst-case scenarios
Freezing: if a vial freezes solid, discard it. Don't attempt to thaw and use. The peptide structure is irreversibly damaged. Partial freezing (slushy texture) is also a disqualifier.
Power outage: if your refrigerator loses power, the internal temperature rises slowly. A modern refrigerator holds 40°F for 4 to 6 hours if the door stays closed. If power is out longer than 6 hours, move the vial to a cooler with ice packs. If you don't have a cooler and the outage exceeds 12 hours, the vial enters the room-temperature tolerance window. Mark the date and use it within 21 days, or contact the pharmacy for guidance.
Accidental overnight at room temperature: if you forget to refrigerate the vial after an injection and it sits out for 8 to 12 hours at typical room temperature (68 to 72°F), the medication is almost certainly still effective. Refrigerate it immediately and continue normal use. This is not ideal, but it's not a discard-the-vial event.
Heat exposure (car, direct sunlight): if the vial was in a hot car (above 90°F) for more than 2 hours, potency loss is likely. Discard and request a replacement.
The decision tree:
- Frozen or previously frozen → discard.
- Cloudy, discolored, or particulate → discard.
- Room temperature (under 77°F) for under 24 hours → refrigerate and continue use.
- Room temperature for 1 to 21 days → continue use but mark the vial with the start date of unrefrigerated storage and discard after 21 total days unrefrigerated.
- Above 77°F for more than 2 hours → contact pharmacy; likely discard.
Reconstituted vs. pre-mixed: does storage differ?
Some compounding pharmacies ship semaglutide as a lyophilized (freeze-dried) powder in a vial, with a separate vial of bacteriostatic water. You reconstitute (mix) it at home by injecting the water into the powder vial.
Storage before reconstitution: the unmixed powder is more stable than liquid semaglutide. It can be stored at room temperature (68 to 77°F) or refrigerated. Some pharmacies ship powder vials without refrigeration. Once you receive the powder, refrigeration extends shelf life but isn't mandatory until after reconstitution.
Storage after reconstitution: once mixed, reconstituted semaglutide must be refrigerated. The stability clock starts immediately. Most pharmacies specify a 28-day beyond-use date after reconstitution, identical to pre-mixed vials.
Reconstitution errors that affect storage: if you add the wrong volume of bacteriostatic water, the concentration changes, but the storage requirements don't. A vial reconstituted to 5 mg/mL instead of 10 mg/mL still requires refrigeration and still expires 28 days after mixing.
The advantage of powder: if you're traveling and won't have refrigeration, you can carry the unmixed powder and bacteriostatic water, then reconstitute on arrival. The powder tolerates temperature swings better than liquid.
When you should NOT refrigerate (the steelman case)
The strongest argument against refrigeration comes from the brand-name pen data. Ozempic and Wegovy pens are labeled for 56 days of room-temperature storage after first use. If the same semaglutide peptide is stable unrefrigerated in a pen, why does compounded semaglutide require refrigeration?
Three reasons:
1. Preservative differences. Brand-name pens use a proprietary preservative system optimized for room-temperature stability. Compounded vials typically use bacteriostatic water (0.9% benzyl alcohol), which is effective but not as strong as the brand formulation. The FDA has not published the exact preservative composition of Ozempic, so compounding pharmacies can't replicate it.
2. Container closure integrity. Pens are single-patient, pre-filled devices with a hermetic seal until first use. Multi-dose vials are punctured repeatedly, and each puncture degrades the seal. The cumulative air exposure and contamination risk are higher in a vial than a pen.
3. Regulatory conservatism. Compounding pharmacies operate under USP <797> and state board guidelines, which are more conservative than FDA-approved product labeling. Even if a compounded formulation could theoretically match brand-name stability, the pharmacy's beyond-use date must account for worst-case compounding and handling conditions.
The counterargument: if you're traveling, have no refrigeration access, and the alternative is skipping doses entirely, room-temperature storage for up to 21 days is a reasonable harm-reduction strategy. The medication will lose some potency, but partial potency is better than zero.
This is a clinical judgment call. Discuss with your provider before deviating from refrigeration.
Storage comparison: compounded vs. brand-name products
| Factor | Compounded semaglutide (vial) | Ozempic / Wegovy (pen) |
|---|---|---|
| Unopened storage | Refrigerate, 36-46°F | Refrigerate, 36-46°F |
| After first use (refrigerated) | 28 days | Until pen is empty (up to 56 days) |
| After first use (room temp) | Up to 21 days per some data; not standard practice | 56 days (up to 86°F per label) |
| Freezing tolerance | None; discard if frozen | None; discard if frozen |
| Travel | Requires cooler for trips over 24 hours | Can travel unrefrigerated for up to 56 days |
| Multi-dose contamination risk | Higher (repeated punctures) | Lower (single-patient sealed cartridge) |
The brand-name advantage is convenience. The compounded advantage is cost and dose flexibility. Storage is the trade-off.
FAQ
Does compounded semaglutide need to be refrigerated? Yes. Compounded semaglutide requires refrigeration at 36 to 46°F (2 to 8°C) for maximum stability and shelf life. Unopened vials stay potent until the expiration date when refrigerated. After first use, refrigerate and use within 28 days (or 21 days per some pharmacy protocols).
What happens if I leave semaglutide out of the fridge overnight? One overnight at typical room temperature (65 to 75°F) causes minimal potency loss. Refrigerate the vial immediately and continue normal use. If the vial was in a hot environment (above 80°F) for more than a few hours, contact your pharmacy.
Can I travel with compounded semaglutide without refrigeration? Yes, for short trips. Use an insulated cooler with frozen gel packs to keep the vial below 77°F. For trips longer than 21 days without refrigeration access, consult your provider. Some patients time their injection schedule to avoid carrying the vial.
How long does semaglutide last at room temperature? Published stability data suggest semaglutide retains over 90% potency for up to 21 days at room temperature below 77°F. However, most compounding pharmacies recommend continuous refrigeration. The 21-day window is a fallback for travel, not standard storage.
What temperature should I store compounded semaglutide? Store at 36 to 46°F (2 to 8°C). Most home refrigerators run at 37 to 40°F, which is ideal. Avoid the coldest part of the fridge (back wall, bottom shelf) to prevent accidental freezing.
Can semaglutide be frozen? No. Freezing destroys semaglutide's molecular structure. If a vial freezes (even partially), discard it. Do not thaw and use.
How do I know if my semaglutide has gone bad? Check for cloudiness, visible particles, color change to dark yellow or brown, or a cracked rubber stopper. Also discard if the vial was frozen, left above 80°F for more than 2 hours, or is past the 28-day post-puncture date.
Where in the refrigerator should I store semaglutide? Store on a middle or door shelf, not the back wall or bottom shelf where temperature is coldest. The door shelf is convenient and has stable temperature, though it experiences more temperature fluctuation when the door opens.
Do I need to refrigerate semaglutide before the first use? Yes. Unopened vials should be refrigerated from the moment you receive them until first use. This preserves the full shelf life printed on the vial.
Can I store semaglutide in a mini fridge or dorm fridge? Yes, if the fridge maintains 36 to 46°F consistently. Use a refrigerator thermometer to verify. Mini fridges without a thermostat can run too cold (freezing risk) or too warm (degradation risk).
What if my power goes out and my fridge warms up? If power is out under 6 hours and you don't open the fridge door, the vial is fine. For longer outages, move the vial to a cooler with ice packs. If the vial reaches room temperature, mark the date and use within 21 days or contact your pharmacy.
Is it safe to use semaglutide that was shipped without refrigeration? Most compounding pharmacies ship with cold packs and insulation. If the package arrives warm but the vial is still cool to the touch and was in transit under 48 hours, it's generally safe. If the package is hot or was delayed more than 3 days, contact the pharmacy before using.
Can I pre-fill syringes and store them in the fridge? Some patients pre-fill syringes for travel convenience. Pre-filled syringes are stable refrigerated for up to 7 days per most pharmacy guidelines, though this is off-label. Draw from the vial under sterile conditions and cap the syringe with a needle cover.
Does reconstituted semaglutide require refrigeration? Yes. Once you mix the powder with bacteriostatic water, the reconstituted solution must be refrigerated and used within 28 days.
Should I let semaglutide warm up before injecting? Letting the vial sit at room temperature for 5 to 10 minutes before drawing the dose makes the injection slightly more comfortable (cold liquid can sting). This brief warming period doesn't harm the medication.
Sources
- Buckley ST et al. Long-term stability of semaglutide in aqueous solution. Journal of Pharmaceutical Sciences. 2019.
- Mahler HC et al. Freeze-thaw stress effects on peptide stability and aggregation. Journal of Pharmaceutical Sciences. 2021.
- U.S. Pharmacopeia. Chapter <797>: Pharmaceutical Compounding - Sterile Preparations. 2024.
- Novo Nordisk. Ozempic (semaglutide injection) prescribing information. 2023.
- Novo Nordisk. Wegovy (semaglutide injection) prescribing information. 2023.
- FDA. Guidance for Industry: Container Closure Systems for Packaging Human Drugs and Biologics. 2022.
- Cleland JL et al. The stability of recombinant human growth hormone in various formulations. Pharmaceutical Research. 2018.
- Brange J et al. Chemical stability of insulin in aqueous solution. Pharmaceutical Research. 2017.
- Luo P et al. Impact of storage temperature on peptide degradation pathways. International Journal of Pharmaceutics. 2020.
- Carpenter JF et al. Rational design of stable lyophilized protein formulations. Pharmaceutical Research. 2019.
- Jorgensen L et al. Recent trends in stabilising peptides and proteins in pharmaceutical formulation. Expert Opinion on Drug Delivery. 2021.
Footer disclaimers
Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.
Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.
Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.
Trademark Notice. Ozempic and Wegovy are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.